Collaboration with Dr. Slamon at the University of California, Los Angeles, to explore potential clinical indications in breast cancer for a number of Zymeworks' bi-specific antibodies.
Collaboration with Professor Boulanger, Assistant Professor of Biochemistry & Microbiology at the University of Victoria, Canada, to use X-ray crystallography to better understand the structure-function relationships between therapeutic antibodies and disease targets.
Zymeworks' academic relationships are facilitated in part through an ongoing relationship with the Mitacs, a national not-for-profit research organization developing the next generation of innovators with vital scientific and business skills.
Collaboration with Professor B. Mario Pinto, Ph.D., VP Research for Simon Fraser University, utilizing Zymeworks' ZymeCAD™ platform for computational antibody modeling and the development of enzyme-based tuberculosis therapeutic agents.
Collaboration with Professor Anne Condon, Ph.D. and Associate Professor Holger Hoos, Ph.D. at the University of British Columbia in the field of Ligand Force Field Parameter Optimization for co-factors and other small molecules in Molecular Dynamics simulations.
If you are interested in exploring partnering opportunities with Zymeworks, please contact us at firstname.lastname@example.org.